The medication, originally developed to treat celiac disease, could provide significant relief for young MIS-C patients. 

Don't give up on eating vegetables quite yet—but a new analysis in Frontiers in Nutrition does suggest they can't protect you from CVD all on their own. 

The team's findings, one researcher said, "could eventually make a huge impact on many patients lives."

Researchers focused on 30-day outcomes, sharing their findings in the American Journal of Cardiology.

An estimated 1.2 million additional patients are now candidates for the company's small CardioMEMs HF monitor. 

10-year data from the ROOBY study found that there was little difference in outcomes between the two forms of heart bypass surgery. 

The public comment period for these recommendations ends on March 21.

SNMMI is fighting for expanded coverage for amyloid PET, including broadening accepted sites of service, among other changes.